mometasone | Elok cream 0.1%, 15 g
Special Price
$13.58
Regular Price
$22.00
In stock
SKU
BID462782
Latin name
ELOCOM
ELOCOM
Latin name
ELOCOM
release form
ointment
Indications
Reducing and eliminating inflammation and pruritus in dermatoses, amenable to glucocorticosteroid therapy in adults and children over the age of 2 years.
Contraindications
Hypersensitivity.
Pregnancy and lactation
Adequate, well-controlled studies of the teratogenic potential of mometasone furoate when used during pregnancy have not been conducted. The use of cream, ointment or lotion Elokom during pregnancy is possible only if the expected benefits of treatment for the mother will outweigh the potential risk to the fetus.
With systemic use, glucocorticosteroids appear in breast milk, which can lead to a slowdown in the growth of the baby, effects on the endogenous synthesis of glucocorticosteroids and other adverse effects. There is no evidence that systemic absorption of glucocorticosteroids when administered topically can cause their detectable amounts to appear in breast milk. However, due to the fact that many drugs are excreted in breast milk, nursing women should use cream, ointment, Elok lotion with caution.
Composition
1 g of ointment contains:
Active ingredient: mometasone furoate 1 mg
Excipients: hexylene glycol, phosphoric acid, propylene glycol stearate, white wax, white petrolatum, white water, purified water.
Dosage and administration
Apply a thin layer to the affected skin once a day.
Side effects of
In controlled clinical trials in 812 patients, the incidence of adverse events associated with the use of Elok ointment was 4.8%. Burning, tingling, itching, skin atrophy, furunculosis were noted, there were reports of the appearance of rosacea. In controlled clinical trials in children aged 2 to 12 years (n = 74), the frequency of adverse events (burning, itching, furunculosis) associated with the use of ointment was approximately 7%.
Overdose
When used topically in large doses, absorption of the drug in quantities sufficient to show systemic side effects is possible.
Storage Conditions
The product should be stored at 2 РC to 25 РC.
Shelf life
3 years.
Deystvuyushtee substance
mometasone
Terms and conditions
prescription
dosage form
ointment
Possible product names
ELOK 0.1% 15.0 CREAM
ELOK 0.1% 15.0 OINTMENT
ELOK 0.1% 15g ointment
ELOK 0.1% Ointment 15g
ELOK 0.1% Ointment d / outdoor approx. 15g (R)
ELOCOM
release form
ointment
Indications
Reducing and eliminating inflammation and pruritus in dermatoses, amenable to glucocorticosteroid therapy in adults and children over the age of 2 years.
Contraindications
Hypersensitivity.
Pregnancy and lactation
Adequate, well-controlled studies of the teratogenic potential of mometasone furoate when used during pregnancy have not been conducted. The use of cream, ointment or lotion Elokom during pregnancy is possible only if the expected benefits of treatment for the mother will outweigh the potential risk to the fetus.
With systemic use, glucocorticosteroids appear in breast milk, which can lead to a slowdown in the growth of the baby, effects on the endogenous synthesis of glucocorticosteroids and other adverse effects. There is no evidence that systemic absorption of glucocorticosteroids when administered topically can cause their detectable amounts to appear in breast milk. However, due to the fact that many drugs are excreted in breast milk, nursing women should use cream, ointment, Elok lotion with caution.
Composition
1 g of ointment contains:
Active ingredient: mometasone furoate 1 mg
Excipients: hexylene glycol, phosphoric acid, propylene glycol stearate, white wax, white petrolatum, white water, purified water.
Dosage and administration
Apply a thin layer to the affected skin once a day.
Side effects of
In controlled clinical trials in 812 patients, the incidence of adverse events associated with the use of Elok ointment was 4.8%. Burning, tingling, itching, skin atrophy, furunculosis were noted, there were reports of the appearance of rosacea. In controlled clinical trials in children aged 2 to 12 years (n = 74), the frequency of adverse events (burning, itching, furunculosis) associated with the use of ointment was approximately 7%.
Overdose
When used topically in large doses, absorption of the drug in quantities sufficient to show systemic side effects is possible.
Storage Conditions
The product should be stored at 2 РC to 25 РC.
Shelf life
3 years.
Deystvuyushtee substance
mometasone
Terms and conditions
prescription
dosage form
ointment
Possible product names
ELOK 0.1% 15.0 CREAM
ELOK 0.1% 15.0 OINTMENT
ELOK 0.1% 15g ointment
ELOK 0.1% Ointment 15g
ELOK 0.1% Ointment d / outdoor approx. 15g (R)
Submit your review to Earn 10 Reward Points click here to login
Write Your Own Review